1. Amarantus Biosciences Awarded Research Grant by Center of Excellence in

    Amarantus BioSciences, Inc. (OTCQB: AMBS), a biotechnology company developing new treatments for brain-related disorders including Parkinson's disease and Traumatic Brain Injuries (TBI) centered on its unique proprietary anti-apoptotic therapeutic protein known as MANF, today announced a Translational Research Grant award from the University of Massachusetts' Pioneer Valley Life Sciences Institute's Center of Excellence in Apoptosis Research (CEAR).  The Institute is a joint research venture of Baystate Medical Center and the University of Massachusetts Amherst. Investigators will exploit publicly available genomics databases to identify potentially new therapeutic targets for MANF-based therapeutics, and then validate those hypotheses in cell-based laboratory ...

    Read Full Article

    Login to comment.

  1. Categories

    1. Industry Clusters:

      Aerospace/Defense, Business Development, Creative Economy, Education, Energy, Entrepreneurship, Financial Services, Green Region, Health Care, Information Technology, Life Sciences, Logistics, Manufacturing, Medical Devices, Paper Manufacturing, Plastics, Retail, Tourism, Transportation, Workforce
  2. Topics Mentioned